Press release

HKCF acted as lead advisor to Karo Healthcare

Date
August 2, 2023
Location
Stockholm
All news

Karo Healthcare announces the acquisition of the rights to the global OTC brand Lamisil® from Haleon UK Holdings Ltd. for a total consideration of GBP 235m (EUR 274m).

Source: Karo Healthcare